Lifecore Biomedical, Inc. De (LFCR) Receivables (2011 - 2025)

Lifecore Biomedical's Receivables history runs 15 years deep, the most recent figure standing at $22.1 million for Q2 2025.

• In Q2 2025, Receivables rose 8.78% year-over-year to $22.1 million; the TTM figure through May 2025 stood at $22.1 million (up 8.78% YoY), while the FY2025 annual figure was $22.1 million, down 37.17% from the prior year.
• Receivables was $22.1 million for Q2 2025 at Lifecore Biomedical, down from $22.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $53.6 million in Q1 2022 to a low of $13.7 million in Q4 2023.
• Historically, Receivables has averaged $32.1 million across 5 years, with a median of $35.8 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Receivables tumbled 61.87% in 2023, then surged 163.34% in 2024.
• A 5-year view of Receivables shows it stood at $40.1 million in 2021, then dropped by 10.57% to $35.9 million in 2022, then plunged by 61.87% to $13.7 million in 2023, then surged by 163.34% to $36.0 million in 2024, then plunged by 38.53% to $22.1 million in 2025.
• The last three Receivables figures came in at $22.1 million (Q2 2025), $22.3 million (Q1 2025), and $36.0 million (Q4 2024), per Business Quant data.